SOURCE: HealthSTAR Communications

January 08, 2010 13:00 ET

HealthSTAR's Centron Awarded Agency of Record Assignments

NEW YORK, NY--(Marketwire - January 8, 2010) - HealthSTAR's Centron, a medical communications company, is pleased to announce that they have been awarded agency of record assignments for FRAGMIN® and GLIADEL® Wafer from Eisai Inc.

FRAGMIN is an anticoagulant that prevents the formation of blood clots. GLIADEL Wafer is used to treat brain tumors.

"We are proud to expand our partnership with Eisai," says Marcia McLaughlin, president of Centron. "FRAGMIN and GLIADEL Wafer are important medicines. We look forward to becoming strategic and creative members of the brand teams."

About Centron

Centron is a full-service medical communications agency offering senior-level strategic expertise across a range of therapeutic areas. The Centron staff has over 200 years of combined pharmaceutical experience and is committed to building bold, effective, and synergistic communications. Centron is a HealthSTAR Communications company and is based in New York, NY. Learn more about Centron at

About HealthSTAR Communications, Inc.

HealthSTAR Communications is one of the largest marketing services networks in the industry. Its 12 integrated and complementary divisions provide a comprehensive portfolio of traditional and unique services. The HealthSTAR companies have worked with over 96 different pharmaceutical and healthcare manufacturers representing over 207 brands. HealthSTAR's mission is to significantly improve the effectiveness and efficiency of healthcare communications. HealthSTAR offers a full range of marketing services to reach and communicate with all of the stakeholders in healthcare: providers, consumers, purchasers and managers. The company is privately held and based in Mahwah, NJ. Learn more about HealthSTAR Communications at

Contact Information

  • Contact:
    David Schemelia
    HealthSTAR Public Relations
    Email Contact